WELCOME TO

Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.

Our
Services
Focused on supporting life science companies to raise their profile, build corporate value, and generate interest, the services we provide include:
PR & Media
- Press releases
- Article writing and placement
- Media interviews
- Messaging
- Copy writing
- Social media
- Media training
- Events
Marketing
- Conference, event and trade show support
- Marketing literature
- Market research
- Campaign development
- Advertising
- Sponsorship
- Product launches
Design & Branding
- Website design and development
- Print collateral development
- Identity and logo creation
- Brand strategy
- Presentation development
- Video production
Investor Relations
- Business plan development
- Presentation development
- PR targeting the life science trade press read by investors

The
Team
An experienced senior team of specialists in life science communications, with expertise gained in-house and agency side, offering the flexibility to support both early-stage companies and large multinationals.
EVENTS
-
BioSeed Summer 2026
-
Cambridge Wide Open Week 2026
-
Milner Therapeutics Symposium 2026
-
ON Helix 2026 – Disrupting Bio Innovation
Bio-Rad Receives MicroVal Validation for EZ-CheckTM Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits
Methods Certified by MicroVal for Detection of Listeria spp. and Listeria monocytogenes in Food and Environmental Samples HERCULES, Calif. June 02, 2026 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), [...]
Diagnostics start-up LotusDx establishes R&D laboratory at ONE BioHub to advance at-home STI testing
Dedicated R&D space to accelerate development of at-home testing to provide discreet, simple and fast solutions for sexually transmitted infections ONE BioHub’s location and connectivity will facilitate ongoing clinical engagement [...]
Laverock Therapeutics awarded in excess of £2.2M through two innovation grants to support AI-powered platform development and to expand therapeutic programmes outside of oncology
Grants totalling in excess of £2.2M awarded from two industry leading innovation funds The new grants will support the development of Laverock’s single-cell and AI powered gene-control platform, alongside pipeline [...]






















